T-Track® TB Stimulation - ARCSA Registration 1dd56f523cea599d4cc3eb53c89e86dd
Access comprehensive regulatory information for T-Track® TB Stimulation in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 1dd56f523cea599d4cc3eb53c89e86dd and manufactured by MIKROGEN GMBH. The device was registered on April 30, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
IN VITRO DIAGNOSTIC TEST FOR STIMULATION OF IMMUNE CELLS IN WHOLE BLOOD HEPARINIZED WITH M. TUBERCULOSIS ESAT-6 AND CFP-10 PROTEINS. T-TRACK TB STIMULATION, IN COMBINATION WITH T-TRACK®® TB QUANT PCR AND ASSOCIATED SOFTWARE, IS DESIGNED TO BE USED AS AN AID IN THE DIAGNOSIS OF M. TUBERCULOSIS INFECTION (INCLUDING ACTIVE DISEASE).